Subclinical leaflet thrombosis and anticoagulation after transcatheter aortic valve replacement: a review

TJ Cahill, AJ Kirtane, M Leon, SK Kodali - JAMA cardiology, 2022 - jamanetwork.com
Importance Subclinical leaflet thrombosis affects approximately 15% of patients after
transcatheter aortic valve replacement (TAVR). The pathophysiology and clinical …

Bioprosthetic aortic valve thrombosis: definitions, clinical impact, and management: a state-of-the-art review

KR Chitturi, AI Aladin, R Braun… - Circulation …, 2024 - ahajournals.org
Bioprosthetic aortic valve thrombosis is frequently detected after transcatheter and surgical
aortic valve replacement due to advances in cardiac computed tomography angiography …

Aortic stenosis and Heyde's syndrome: A comprehensive review

D Lourdusamy, VK Mupparaju… - World journal of …, 2021 - pmc.ncbi.nlm.nih.gov
Heyde's syndrome is an under reported systemic disease of gastrointestinal and cardiac
manifestation in older adults. It is characterized by a triad of aortic stenosis, angiodysplasia …

Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: an LRT substudy

S Bhogal, R Waksman, P Gordon, A Ehsan… - International Journal of …, 2023 - Elsevier
Background Subclinical leaflet thrombosis (SLT) is characterized on computed tomography
(CT) imaging as hypoattenuated leaflet thickening (HALT), reduced leaflet motion (RELM) …

Platelets: implications in aortic valve stenosis and bioprosthetic valve dysfunction from pathophysiology to clinical care

SL Sellers, GS Gulsin, D Zaminski, R Bing… - Basic to Translational …, 2021 - jacc.org
Aortic stenosis (AS) is the most common heart valve disease requiring surgery in developed
countries, with a rising global burden associated with aging populations. The predominant …

Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study

GA Medranda, N Hanna, M Buchbinder… - …, 2022 - pmc.ncbi.nlm.nih.gov
Background Given enough time, transcatheter heart valves (THVs) will degenerate and may
require reintervention. Redo transcatheter aortic valve implantation (TAVI) is an attractive …

Efficacy and outcomes of antiplatelet therapy versus oral anticoagulants in patients undergoing transcatheter aortic valve replacement: a systematic review and meta …

A Goyal, FQ Abbasi, MD Tariq… - Annals of Medicine …, 2024 - journals.lww.com
Background: Recent guidelines suggest that antiplatelet therapy (APT) is the standard of
care in the absence of long-term oral anticoagulation (OAC) indications in patients post …

Leaflet thrombosis in transcatheter aortic valve intervention: Mechanisms, prevention, and treatment options

O Koren, V Patel, T Chakravarty, H Jilaihawi… - Frontiers in …, 2023 - frontiersin.org
Introduction Transcatheter aortic valve intervention (TAVR) has emerged as a promising
alternative to surgical aortic valve replacement for patients with severe aortic stenosis …

[HTML][HTML] Cerebrovascular events after transcatheter aortic valve implantation

P Reddy, I Merdler, I Ben-Dor… - …, 2024 - eurointervention.pcronline.com
Periprocedural stroke after transcatheter aortic valve implantation (TAVI) remains a
significant issue, which is associated with high morbidity, and is increasingly important as …

Cardiovascular CT, MRI, and PET/CT in 2021: review of key articles

G Tzimas, DT Ryan, DJ Murphy, JA Leipsic, JD Dodd - Radiology, 2022 - pubs.rsna.org
This review focuses on three key noninvasive cardiac imaging modalities—cardiac CT
angiography (CTA), MRI, and PET/CT—and summarizes key publications in 2021 relevant …